Target intelligence / Profile preview

Mycobacterium tuberculosis Antigen Presentation (N/A)

Target
N/A
Molecular classification
Antigen processing and presentation pathway
01

Overview

Mycobacterium tuberculosis antigen presentation is a complex process involving macrophages and dendritic cells that present mycobacterial antigens via MHC class I and II pathways to T cells. M. tuberculosis actively modulates this process to evade immune detection by inhibiting MHC expression, disrupting antigen processing, manipulating the phagosomal environment, and utilizing specialized secretion systems like ESX-1 to control antigen access to the presentation pathways. Secreted antigens like ESAT-6, Ag85B, and CFP-10 are immunodominant and serve as key vaccine targets. Understanding these mechanisms is crucial for developing effective vaccines that can overcome the bacterium's evasion strategies.

02

Mechanism of action

N/A

03

Biological functions

Immune responseAntigen processingAntigen presentationT cell activationMHC class I presentationMHC class II presentation
04

Disease associations

TuberculosisImmune evasionLatent infection
05

Safety considerations

Immune evasion leading to chronic infectionPotential for vaccine failure due to immune subversion
06

Biomarkers

ESAT-6Ag85BCFP-10

Beyond the preview

Go deeper on Mycobacterium tuberculosis Antigen Presentation (N/A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterium tuberculosis Antigen Presentation (N/A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call